β-defensin-3 negatively regulates TLR4-HMGB1 axis mediated HLA-G expression in IL-1β treated glioma cells

Cellular Signalling

Volumn 25, Issue 3, 2013, Pages 682-689

  Gupta, Piyushi ^a   Ghosh, Sadashib ^a   Nagarajan, Ashwat ^a   Mehta, Veer Singh ^b   Sen, Ellora ^a  

^a NATIONAL BRAIN RESEARCH CENTRE   (India)

^b Paras Hospitals   (India)

Author keywords

defensin 3; HIF 1 ; HLA G; HMGB1; TLR4

Indexed keywords

BETA DEFENSIN 3; HIGH MOBILITY GROUP B1 PROTEIN; HLA G ANTIGEN; INTERLEUKIN 1BETA; TOLL LIKE RECEPTOR 4;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; INFLAMMATION; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BETA-DEFENSINS; CELL LINE, TUMOR; GLIOMA; HLA-G ANTIGENS; HMGB1 PROTEIN; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84872413260     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.12.001     Document Type: Article

References (40)

1. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., DeMars R. Science (New York, N.Y.) 1990, 248(4952):220-223.
2. Rouas-Freiss N., Moreau P., Ferrone S., Carosella E.D. Cancer Research 2005, 65(22):10139-10144.
3. Paul P., Rouas-Freiss N., Khalil-Daher I., et al. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(8):4510-4515.
4. Wiendl H., Mitsdoerffer M., Hofmeister V., et al. Journal of Immunology 2002, 168(9):4772-4780.
5. Moreau P., Flajollet S., Carosella E.D. Journal of Cellular and Molecular Medicine 2009, 13(9B):2973-2989.
6. Mouillot G., Marcou C., Zidi I., et al. Human Immunology 2007, 68(4):277-285.
7. Sharma V., Dixit D., Koul N., Mehta V.S. Journal of Molecular Medicine (Berlin, Germany) 2011, 89(2):123-136.
8. Erlandsson Harris H., Andersson U. European Journal of Immunology 2004, 34(6):1503-1512.
9. Sha Y., Zmijewski J., Xu Z., Abraham E. Journal of Immunology 2008, 180(4):2531-2537.
10. Park J.S., Svetkauskaite D., He Q., et al. The Journal of Biological Chemistry 2004, 279(9):7370-7377.
11. Chen R., Alvero A.B., Silasi D.A., Steffensen K.D., Mor G. Oncogene 2008, 27(2):225-233.
12. Tsung A., Klune J.R., Zhang X., et al. The Journal of Experimental Medicine 2007, 204(12):2913-2923.
13. Tewari R., Choudhury S.R., Ghosh S., Mehta V.S., Sen E. Journal of Molecular Medicine 2011, Berlin, Germany.
14. Mittal D., Saccheri F., Venereau E., Pusterla T., Bianchi M.E., Rescigno M. The EMBO Journal 2010, 29(13):2242-2252.
15. Yang H., Hreggvidsdottir H.S., Palmblad K., et al. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(26):11942-11947.
16. Dhople V., Krukemeyer A., Ramamoorthy A. Biochimica et Biophysica Acta 2006, 1758(9):1499-1512.
17. Semple F., MacPherson H., Webb S., et al. European Journal of Immunology 2011, 41(11):3291-3300.
18. Kesting M.R., Loeffelbein D.J., Hasler R.J., et al. Cancer Investigation 2009, 27(5):575-581.
19. Jin G., Kawsar H.I., Hirsch S.A., et al. PloS One 2010, 5(6):e10993.
20. Gobin S.J., Biesta P., de Steenwinkel J.E., Datema G., van den Elsen P.J. The Journal of Biological Chemistry 2002, 277(42):39525-39531.
21. HoWangYin K.Y., Alegre E., Daouya M., Favier B., Carosella E.D., LeMaoult J. Cellular and Molecular Life Sciences 2010, 67(7):1133-1145.
22. Dixit D., Sharma V., Ghosh S., Mehta V.S., Sen E. Cell Death & Disease 2012, 3:e271.
23. Ghildiyal R., Dixit D. E 2012, Molecular Carcinogenesis, Sen.
24. Hartman N.C., Nye J.A., Groves J.T. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(31):12729-12734.
25. Tewari R., Sharma V., Koul N., Sen E. Journal of Neurochemistry 2008, 107:616-627.
26. Tewari R., Sharma V., Koul N., et al. Molecular Oncology 2009, 3(1):77-83.
27. Maki G., Hayes G.M., Naji A., et al. Leukemia 2008, 22(5):998-1006.
28. Friese M.A., Platten M., Lutz S.Z., et al. Cancer Research 2003, 63(24):8996-9006.
29. Zilberman S., Schenowitz C., Agaugue S., et al. European Journal of Immunology 2012, 42(6):1599-1608.
30. Menendez L., Walker L.D., Matyunina L.V., Totten K.A., Benigno B.B., McDonald J.F. Molecular Cancer 2008, 7:43.
31. Bassi R., Giussani P., Anelli V., et al. Journal of Neuro-Oncology 2008, 87(1):23-33.
32. Mollica L., De Marchis F., Spitaleri A., et al. Chemistry & Biology 2007, 14(4):431-441.
33. Kruger B., Krick S., Dhillon N., et al. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(9):3390-3395.
34. Apetoh L., Ghiringhelli F., Tesniere A., et al. Immunological Reviews 2007, 220:47-59.
35. Semple F., Webb S., Li H.N., et al. European Journal of Immunology 2010, 40(4):1073-1078.
36. Barsoum I.B., Hamilton T.K., Li X., et al. Cancer Research 2011, 71(24):7433-7441.
37. Jung Y., Isaacs J.S., Lee S., Trepel J., Liu Z.G., Neckers L. The Biochemical Journal 2003, 370(Pt 3):1011-1017.
38. Zagzag D., Zhong H., Scalzitti J.M., Laughner E., Simons J.W., Semenza G.L. Cancer 2000, 88(11):2606-2618.
39. Huang B., Zhao J., Li H., et al. Cancer Research 2005, 65(12):5009-5014.
40. Liu Z., Falo L.D., You Z. Journal of Immunology 2011, 187(1):118-125.